The HIV prevention drug Truvada (PrEP) will be listed on the Pharmaceutical Benefits Scheme from this Sunday, moving Australia closer to achieving its goal of ending new HIV transmissions by 2020.
- Associate Professor, Monash University
Efficacy is estimated to be as high as 99% in men who have sex with men who take Truvada daily.
The field of HIV treatment and prevention has been freshly energised by the findings from several recent clinical trials. Maintaining the momentum of scientific discoveries and breakthroughs is critical…
The rate of newly diagnosed HIV infections in Australia has risen by 10% in 12 months – the largest increase in 20 years, a new report shows. Last year, 1,253 cases of HIV were diagnosed, with unprotected…
Australia has seen a notable rise in HIV infections over the last 12 months, say researchers at the University of New South Wales. The 2012 HIV, viral hepatitis and sexually transmissible infections in…
Contact Edwina for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: straya
- X (formerly Twitter): @edwina_wright
- Article Feed
- Joined
